Skip to main content

A rare case of Immunoglobulin A dominant post-infectious glomerulonephritis (IgA PIGN) in a young patient



Immunoglobulin A dominant postinfectious glomerulonephritis (IgA PIGN) is a unique medical entity that is rare in the paediatric population. It usually presents with severe renal failure, heavy proteinuria, hypertension, and hypocomplementemia and frequently has an unfavourable prognosis. IgA PIGN generally occurs in association with staphylococcal infections and diabetes mellitus in adult patients. Other pathogens include Escherichia coli and Streptococcus sp. Immunofluorescence studies of kidney biopsy samples show IgA as dominant or codominant antibody.

Case presentation

We encountered a 3-year-old girl with IgA PIGN presenting with acute renal failure, oedema, hypertension, and heavy proteinuria of 7955 mg/g creatinine. Renal biopsy specimens showed diffuse glomerular endocapillary hypercellularity with prominent neutrophil and monocyte infiltration on light microscopy. Strong deposits of IgA and C3 were observed along the glomerular basement membranes and the mesangium by immunofluorescence microscopy, and electron microscopy revealed the presence of subepithelial humps.

The patient was managed with steroid (and probatory antibiotic) therapy and is now undergoing follow-up, with a significant improvement 6 months after the initial presentation (glomerular filtration rate (GFR) and cystatin C clearance rate of 165 ml/min/1.73m2 and 106 ml/min/1.73m2, respectively). No signs of bacterial infection were detectable.


This variant of IgA PIGN must be distinguished from other clinical entities, especially IgA nephropathy (mesangial IgA deposits) and postinfectious glomerulonephritis (C3, IgG and occasional IgM capillary loop deposits with or without mesangial distribution), since patients with IgA PIGN may require steroid treatment in addition to antibiotic therapy. Differential diagnosis should also include C3 glomerulopathy.

IgA PIGN is a recently identified disease entity that generally manifests in adult patients with both IgA and C3 mesangial and glomerular capillary wall deposits. We present a biopsy-proven case of IgA PIGN that manifested in a patient at an exceptionally young age and that has had a good clinical outcome. To the best of our knowledge, this is the youngest IgA PIGN patient reported thus far.

Peer Review reports


IgA-dominant PIGN is a newly recognized variant of PIGN. It is characterized by proliferative glomerulonephritis seen in light microscopy (LM) with dominant or codominant mesangial and glomerular capillary wall deposits of IgA detected by immunofluorescence (IF) in combination with hump-like deposits obtained by electron microscopy (EM) [1].

The Arkana laboratory database gathered more than 80,000 kidney biopsies and identified about 160 cases of IgA PIGN. Patients were all adults, and the majority were over 40 years of age. About 50% had a comorbidity of diabetes mellitus. Many patients were tested positive for methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-susceptible Staphylococcus aureus (MSSA), and in some of these patients ANCA testing was positive [2, 3]. IF has identified IgA as a dominant or a co-dominant antibody, with a higher potency detected for C3 than IgA. Subepithelial humps and focal necrotizing glomerulonephritis were present in some of the cases [2].

Typical IgA-dominant PIGN has been described in only three children below 18 years of age with a lowest age of 12-years [4, 5]. IgA PIGN typically presents with acute renal failure and severe proteinuria in the majority of cases. Hypocomplementemia is common and can be detected in two-thirds of patients [6].

Conditions predisposing a patient to the develop IgA-dominant PIGN include old age, diabetes, and Staphylococcus aureus infections, furthermore cancer, drug and alcohol abuse [6]. IgA PIGN has been linked to staphylococcal infections but also to infections with other pathogens including E. coli, Enterococcus species and HIV. This type of glomerulonephritis therefore appears to be postinfectious [6,7,8,9,10]. Pharyngitis has been superseded by skin, urinary or pulmonary infections [6, 11,12,13,14,15].

IgA PIGN variants should be differentiated from IgA nephropathy. Features supporting the diagnosis of IgA PIGN over IgA nephropathy include manifestation at an older age, acute kidney failure, a documented staphylococcal infection and low serum complement (C3). Histologic features of IgA PIGN comprise endocapillary hypercellularity, a strong infiltration of neutrophils, a marked deposition of C3 compared to IgA, and characteristic subepithelial humps visible on electron microscopy [1, 2].

The diagnosis of IgA-dominant PIGN is not always easy and the awareness of pediatric IgA-dominant PIGN should improve. This is of importance as it affects the choice of treatment modalities. However, there is no consensus on the management of IgA PIGN. The early use of antibiotics is highly recommended to effectively treat the underlying bacterial infection [16]. However, IgA-dominant PIGN has also been reported without identification of a causal infection [17]. In the presence of progressive glomerulonephritis steroid therapy should be initiated [4, 16]. Despite these recommendations, complete renal recovery was only observed in less than 20% of adult patients [6].

Case presentation

A 3 year and 2-month-old girl presented to the emergency department with a rash on her legs for 1 day and haematuria for 4 days. There was no accompanying fever. She was started on a course of oral cefaclor for presumed urinary tract infection 2 days ago. Urine culture showed no bacterial growth. Eight weeks earlier, the girl had a purulent nail infection and was treated conservatively. One year earlier, the girl had severe streptococcal tonsillitis. The throat swab at that time was positive for streptococci. Her symptoms improved after 10 days of antibiotic therapy. There was no known kidney disease in the family.

Physical examination revealed a hypertensive patient with a rash on her lower extremities but no peri-articular swelling. The rash disappeared on day 4 after admission. Pedal and eyelid oedema were present. No ear, nose or throat (ENT) pathologies, enlarged lymph nodes or ascites were observed.

Clinical examination demonstrated Glasgow Coma Scale (GCS) score 15, pulse 101 beats/min, capillary refill time 1 second, blood pressure 104/63 mmHg (99.P), respiration rate of 24 breaths/min, oxygen saturation (SpO2) 96%, temperature 36.8 °C, weight 16 kg (75.P), and height 96 cm (39.P).

Investigations showed negativity for myeloperoxidase antibodies, lactoferrin antibodies, proteinase 3 antibodies, bactericidal/permeability-increasing protein antibodies, cathepsin G antibodies, antinuclear antibodies and antineutrophil cytoplasmic antibodies and elevated levels of urea, uric acid, creatinine, perinuclear anti-neutrophil cytoplasmic antibodies, elastase antibodies, IgG and anti-streptolysin. The level of C3 was low (0.260 g/l). The results are shown in the supplementary table (Table 1).

Table 1 Laboratory results at hospital admission

Urinalysis: Dipstick tests showed 3+ proteinuria, haematuria, and leukocyturia. The results were negative for nitrite and showed a normal urine pH. A 24-h urine test showed normal creatinine levels and elevated levels of protein(2.8 g/l), protein/g creatinine(7955 mg/g). See (Table 2).

Table 2 24-h Urine test results

Renal ultrasound showed bilateral enlarged hyperechogenic kidneys. The volumes were 64 cm3 for the right kidney and 70 cm3 for the left kidney. There was no evidence of any urinary transport disorder. Otherwise, an age- appropriate abdominal sonogram was documented (Fig. 1).

Fig. 1
figure 1

Renal ultrasound showing an enlarged hyperechogenic kidney. Otherwise, this was an age-appropriate abdominal sonogram

Echocardiography: There was no left ventricular hypertrophy (LVH) or pericardial effusion. The tricuspid aortic valve and coronary outlets were normal. Physiologic regurgitation was observed in the pulmonary and tricuspid valves. There was no aortic or mitral insufficiency.

Renal biopsy was performed. Light microscopy showed 47 glomeruli, out of which seven showed segmental basal membrane rupture with leakage of necrotic fibrinoid material into the extra-capillary space and adjacent alternating strong extra-capillary proliferation. The remaining glomeruli showed significantly increased mesangial and endocapillary hypercellularity, with focal infiltration of the intra-capillary space by neutrophilic granulocytes and monocytes. The peripheral basal membranes were typical, with podocytes with flat cytoplasm. The afferent arterioles were not affected, and Congo red staining was negative (Fig. 2A and B).

Fig. 2
figure 2

A and B Light microscopy showed moderate expansion of the mesangial matrix with mesangial hypercellularity and segmental endocapillary hypercellularity (black arrows) with intracapillary neutrophils (orange arrows) (PAS stain). Original magnification × 400. C and D Electron microscopy showed proliferation of endothelial and mesangial cells and neutrophils (blue arrow) in the lumen. There are several hump-shaped subepithelial electron-dense deposits (black arrows). Original magnification × 5.000 for C and × 8.000 for D. E and F Immunohistology showed dominant staining for IgA and segmental mesangial hypercellularity. (APAAP stain). Original magnification × 400

Electron microscopy showed glomerular parts with typically structured basement membranes. An increase in mesangial cellularity was observed, along with electron-dense subepithelial humps and mesangial deposits. Endocapillary hypercellularity and granulocytic and monocytic infiltration were prominent (Fig. 2C and D).

Immunofluorescence revealed positive focal segmental mesangial and glomerular basement membrane staining for IgA and complement factor (C1q). The same pattern was observed to a lesser extent for IgG. A positive glomerular basement membrane staining in the form of humps for complement factor C3 was observed. A strong complement factor C3 and Fibrinogen staining was detected in the mesangium. The same pattern was observed to a lesser extent for IgM (Fig. 2E and F).

A causative organism was not identified and based on an initial clinical diagnosis of Henoch-Schoenlein purpura with heavy proteinuria, the girl was initially managed with methylprednisolone 300 mg/m2 i.v for three alternate days, followed by prednisolone p.o. 40 mg/m2. Renal biopsy findings were then consistent with IgA PIGN, and the patient was treated with 10 days of antibiotic therapy consisting of cefuroxime i.v. for 3 days followed by flucloxacillin p.o. for 7 days due to a presumed untreated staphylococcal skin infection (paronychia) 8 weeks prior. Prednisolone 40 mg/m2 p.o. was continued for a total period of 1 week and then weaned over next 6 weeks.

The patient experienced partial renal recovery (decrease in serum creatinine from 0.82 mg/dl to 0.31 mg/dl) and a reduction in nephrotic proteinuria (decline from 7955 mg/g to 782 mg/g creatinine) within 32 days. Her serum C3 level completely normalized on day 25 after admission.

At the 6-month follow-up visit, the patient’s creatinine level had improved to 0.25 mg/dL, with a urine protein to creatinine (UPC) ratio of 132 mg/g.

Discussion and conclusion

IgA PIGN is a rare but increasingly recognized PIGN variant. It has been reported in only 3 children worldwide, the youngest being 12 years old [4, 5].

We here present a 3-year-old child that manifested with nephritic and nephrotic syndrome in the setting of a recent paronychia. She was treated with steroids and antibiotics which was associated with an improvement in kidney function and level of proteinuria. This report raises awareness regarding IgA-dominant PIGN, especially in children. Factors that support this rare diagnosis in this age group include hypocomplementaemia, recent suspected staphylococcal infections and characteristic histological findings in renal biopsy specimens.

IgA dominant PIGN is a recently recognized entity with rising incidence that has to be distinguished from the classical diagnosis of IgA nephropathy on one hand and post-streptococcal PIGN on the other. IgA dominant PIGN and IgA nephropathy share clinical and histological similarities that can mislead in diagnosis, especially if the GN remains undiagnosed for a long time. Satoskar et al. summarized clinical and histological factors that are useful in distinguishing these two disease entities [18, 19]. Leading clinical features that favour IgA PIGN over IgA nephropathy are manifestation at an older age, acute kidney failure, a documented staphylococcal infection and low serum complement (C3). Typical histologic features of IgA PIGN include diffuse endocapillary hypercellularity, marked neutrophil infiltration, enhanced deposition of C3 compared to IgA, and characteristic subepithelial humps visible on electron microscopy [4, 20,21,22]. If several of the above factors are present, IgA dominant PIGN is a likely diagnosis.

Furthermore, IgA nephropathy and IgA PIGN differ in mesangial staining for IgA1 lambda and kappa isoform ratio, which shows a dominance of IgA1 lambda in IgA nephropathy and of IgA1 kappa in IgA PIGN [4, 17, 23].

Unlike classical post-streptococcaI PIGN, which is characterized by C3 deposition, IgA PIGN has a typical IgA deposition [6]. The fact that infection with Staphylococcus spp. can cause either IgA PIGN or acute classic PIGN suggests the existence of additional factors causing renal disease. The type of infection does not completely explain the observed differences in antibodies production. Genetic susceptibility may also play a role [3, 19]. To date, the pathophysiology of IgA dominant PIGN remains unknown to a large extend and some might consider it to be a variation of IgA nephropathy.

Renal biopsy confirmed the diagnosis of IgA PIGN in our patient. Unlike the findings in the study by Nasr et al. [6], in which the subepithelial deposits in cases of IgA PIGN were small and sparse, our findings are therefore more consistent with earlier observations by Haas et al. [4, 24], in that subepithelial deposits were large, numerous, and hump shaped.

To date, there has been no systematic assessment of treatment choices or their effectiveness in the treatment of IgA-dominant PIGN, including steroids [6, 25]. The clinical response is usually favourable when the underlying infection is treated, but in some cases, steroid treatment has been added [7,8,9, 20]. Clinical criteria for the use of steroids are not well defined. It has been suggested that steroid therapy should be considered in patients who do not respond to antibiotics alone [26].

In our report, the patient was followed for a short period (< 1 year) and experienced partial recovery from renal failure and persistent proteinuria. Long-term follow-up is needed to assess the progression of the disease. Nasr et al. noted that only 16% of adult IgA-dominant PIGN patients experienced full recovery of renal function (≤1.2 mg/dl), whereas 43% had persistent renal dysfunction, and 41% progressed to end-stage renal disease (ESRD) [6].

In summary, the prognosis of IgA-dominant PIGN is less favourable than that of typical acute post-infectious glomerulonephritis [4, 12,13,14, 20, 22, 27], in the majority of cases, 70 to 80% start with acute kidney injury, proteinuria, haematuria, and hypocomplimentaemia [4, 6, 12,13,14, 20, 22, 27]. Despite the fact that IgA PIGN seems to be a disease without recurrences and exacerbations that characterize primary IgA nephropathy, only less than 20% of adult patients achieve a complete renal recovery. Data on paediatric patients is scarce and it remains to be observed and discussed in future publications whether the renal prognosis in paediatric age group is more favourable than in adults and elderly.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.



Immunoglobulin A


immunoglobulin A-dominant postinfectious glomerulonephritis


post-infectious glomerulonephritis


light microscopy




electron microscopy


bactericidal/permeability-increasing protein


urine protein to creatinine


  1. Rajakumar V, Noor Mohamed SAK, Kurien AA. IgA dominant postinfectious glomerulonephritis: report of two cases. Indian J Nephrol. 2014;24(3):181–4.

    Article  CAS  Google Scholar 

  2. Gaut JP, Mueller S, Liapis H. IgA dominant postinfectious glomerulonephritis update: pathology spectrum and disease mechanisms. Diagnostic Histopathol. 2017;23(3):126–32.

    Article  Google Scholar 

  3. Boils CL, Nasr SH, Walker PD. Update on endocarditis associated glomerulonephritis. Kidney Int. 2015;87:1241–9.

    Article  Google Scholar 

  4. Haas M, Racusen LC, Bagnasco SM. IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features. Hum Pathol. 2008;39:1309–16.

    Article  CAS  Google Scholar 

  5. Srinivasaraghavan R, Krishnamurthy S, Dubey AK. IgA dominant post-infectious glomerulonephritis in a 12-year-old child. Indian J Pediatr. 2016;83(5):470–2.

    Article  Google Scholar 

  6. Nasr SH, D'Agati VD. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract. 2011;119(1):c18–25.

    Article  CAS  Google Scholar 

  7. Bu R, Li Q, Duan ZY, Wu J, Chen P, Chen XM, et al. Clinicopathologic features of IgA-dominant infection-associated glomerulonephritis: a pooled analysis of 78 cases. Am J Nephrol. 2015;41:98–106.

    Article  CAS  Google Scholar 

  8. Handa T, Kakita H, Tateishi Y, Endo T, Suzuki H, Katayama T, et al. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study. Clin Exp Nephrol. 2018;22:1116–27.

    Article  CAS  Google Scholar 

  9. Kanno M, Tanaka K, Kimura H, Watanabe K, Hayashi Y, Asahi K, et al. Garland-pattern postinfectious glomerulonephritis with IgA-dominant deposition. CEN Case Rep. 2014;3:56–62.

    Article  Google Scholar 

  10. Mascarenhas R, Fogo AB, Steele RW, Baliga R. IgA-dominant postinfectious glomerulonephritis. Clin Pediatr. 2016;55:873–6.

    Article  Google Scholar 

  11. Montseny JJ, Meyrier A, Kleinknecht D, Callard P. The current spectrum of infectious glomerulonephritis: experience with 76 patients and review of the literature. Medicine. 1995;74:63–73.

    Article  CAS  Google Scholar 

  12. Koo TY, Kim GH, Park H. Clinicopathologic features of IgA-dominant Postinfectious glomerulonephritis. Korean J Pathol. 2012;46:105–14.

    Article  Google Scholar 

  13. Worawichawong S, Girard L, Trpkov K, Gough JC, Gregson DB, Benediktsson H. Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection. Hum Pathol. 2011;42:279–84.

    Article  CAS  Google Scholar 

  14. Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, et al. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 1995;47:207–16.

    Article  CAS  Google Scholar 

  15. Handa T, Ono T, Watanabe H, Takeda T, Muso E, Kita T. Glomerulonephritis induced by methicillin-sensitive Staphylococcus aureus infection. Clin Exp Nephrol. 2003;7:247–9.

    Article  Google Scholar 

  16. Nagaba Y, Hiki Y, Aoyama T, et al. Effective antibiotic treatment of methicillin-resistant Staphylococcus aureus-associated glomerulone-phritis. Nephron. 2002;92:297–303.

    Article  CAS  Google Scholar 

  17. Nasr SH, Fidler ME, Valeri AM, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2011;22:187–95.

    Article  Google Scholar 

  18. Satoskar AA, Nadasdy G, Plaza JA, et al. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol. 2006;1:1179–86.

    Article  Google Scholar 

  19. Satosker AA, Suleiman S, Ayoub I, et al. Staphylococcus infection-associated GN-spectrum of IgA staining and prevalence of ANCA in a single center cohort. Clin J Am Soc Nephrol. 2017;6(12):39–49.

    Article  Google Scholar 

  20. Nasr SH, Markowitz GS, Whelan JD, Albanese JJ, Rosen RM, Fein DA, et al. IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum Pathol. 2003;34:1235–41.

    Article  CAS  Google Scholar 

  21. Nasr SH, Share DS, Vargas MT, D’Agati VD, Markowitz GS. Acute poststaphylococcal glomerulonephritis superimposed on diabetic glomerulosclerosis. Kidney Int. 2007;71:1317–21.

    Article  CAS  Google Scholar 

  22. Wen YK, Chen ML. Discrimination between postinfectious IgA-dominant glomerulonephritis and idiopathic IgA nephropathy. Ren Fail. 2010;32:572–7.

    Article  Google Scholar 

  23. Chui SH, Lam CW, Lewis WH, Lai KN. Light-chain ratio of serum IgA1 in IgA nephropathy. J Clin Immunol. 1991;11:219–23.

    Article  CAS  Google Scholar 

  24. Elodie MS, Charlotte J. Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study. Diagn Pathol. 2020;15:62.

    Article  Google Scholar 

  25. Okuyama S, Wakui H, Maki N, Kuroki J, Nishinari T, Asakura K, et al. Successful treatment of post-MRSA infection glomerulonephritis with steroid therapy. Clin Nephrol. 2008;70:344–7.

    Article  CAS  Google Scholar 

  26. Gaut JP, Liapis H. IgA dominant post-infectious glomerulonephritis: pathology and insights into disease mechanisms. Diagn Histopathol. 2013;19:175–81.

    Article  Google Scholar 

  27. Spector DA, Millan J, Zauber N, Burton J. Glomerulonephritis and staphylococcal aureus infections. Clin Nephrol. 1980;14:256–61.

    CAS  PubMed  Google Scholar 

Download references


MK for performing the renal biopsy and HG for providing the histopathology report.


No funding.

Author information

Authors and Affiliations



AS analysed, collected, and interpreted the patient data and was the main manuscript writer. SW was a major contributor to writing, editing, and reviewing the manuscript. All other co-authors (GK, BT, MK, HJG) read and approved the final manuscript. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to A. Saghar.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

The featured patient’s parents gave written consent for the publication of their child’s personal or clinical details along with any identifying images.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saghar, A., Klaus, G., Trutnau, B. et al. A rare case of Immunoglobulin A dominant post-infectious glomerulonephritis (IgA PIGN) in a young patient. BMC Nephrol 23, 333 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: